Clinical trials have started on human volunteers in Europe and the US as Pfizer are testing a new anti-Covid pill which could end future lockdowns.
If the Pfizer clinical trials for the antiviral drug named PF-07321332 are successful it could be rolled out later this year, which will prevent severe Covid illness and could be powerful enough to be resistant against new strains.
The Telegraph newspaper has reported that the tablet has been tested on 60 “clean living” volunteers who are aged between 18-years old and 60.
Professor Penny Ward, from King’s College London said, ‘If they have moved to this stage, they will be quietly optimistic.
“The question will be about how the drug is tolerated… They will be going like the clappers.”
Speaking to the Mirror Online, Chief trial investigator Professor Kevin Blyth, from Glasgow University said, “It would be a huge step forward if antiviral drugs work.
“You don’t have any hospital services being put under enormous pressure because patients never come to the hospital.
“Normal services can function and you don’t have to have lockdown or other draconian control measures.”